Skip to main content

Biocom’s Global Life Science Partnering Conference

When:

February 28, 2018 7:30 amMarch 1, 2018 5:30 pm (PST)

Where:

The Lodge at Torrey Pines
11480 N Torrey Pines Rd
La Jolla, 92037

Registration Closed

CONFERENCE IS SOLD OUT: TO BE ADDED TO THE WAITLIST PLEASE EMAIL ANGELA WIESZCHOWKSKI AT ANGELAW@BIOCOM.ORG

Biocom's 8th Annual Global Life Science Partnering Conference is an exclusive global partnering and networking forum that brings together senior executives, bankers, venture capitalists, and business development professionals from leading pharmaceutical and biotech companies. Join us in San Diego on February 28th and March 1st, 2018, where industry leaders will debate current trends, companies will showcase their latest technologies and all attendees will have the opportunity to schedule one-on-one meetings with leading deal-makers.

DOWNLOAD CONFERENCE AGENDA

New to 2018: BIO’s One-on-One Partnering System:
We heard your concerns and feedback from 2017 and have changed our partnering system platform for our 2018 conference. The Global Life Science Partnering Conference now utilizes BIO’s One-on-One Partnering System. Additionally, after exceeding our meeting space in 2017, we are excited to announce that we have added additional meeting locations and tables for one-on-one meetings in 2018. Participating in one-on-one partnering at the Biocom Global Life Science Partnering Conference is a unique and valuable experience that allows you to meet one-on-one in a private setting with attendees of your choice throughout the length of the entire conference. The partnering system will open the week of January 15th, 2018.

Attendee Benefits:

300+ Attendees
350+ One-on-One Partnering Meetings
6 Panel Discussions with Industry Thought Leaders from Around the Globe
1 Fireside Chat from Industry Luminaries
1 Keynote Presentation
Access to Emerging Companies Seeking Funding and Partnerships
Gala Networking Reception Situated Atop La Jolla’s Coastline & Torrey Pines Golf Course

Meet Our Conference Speakers:

Jerel Banks, Chief Investment Officer, NantVentures
Paul Biondi, SVP, Head of Business Development, Bristol-Myers Squibb
Kathy Bowdish, Vice President Global R&D and Head of Sunrise Ventures, Sanofi U.S.
Paola Casarosa, Corporate Vice President Licensing, Boehringer Ingelheim
Hannah Chang, Investment Director, Wu Capital
Jon Edwards, Principal, Medicxi
Daniel Estes, Ph.D., Partner, Frazier Healthcare Partners
Chris Haskell, Vice President and Head, West Coast Innovation Center, Bayer
Daria Hazuda, Vice President of Infectious Diseases Discovery, Merck Research Laboratories
Natasha Hernday, Senior VP Corporate Development, Seattle Genetics
John Hood, Founder & CEO, Impact Biomedicines
David Kabakoff, Executive Partner, Private Equity, Sofinnova Ventures
Balraj Kakkar, Partner and Managing Director, Ernst & Young LLP
Kim Kamdar, Partner, Domain Associates
Syed Kazmi, Executive Director, Business Development, Amgen
Chau Khuong, Private Equity Partner, Orbimed
Tomas Landh, Innovation Sourcing Vice President, Senior Principal Scientist R&D External Innovation Sourcing, Novo Nordisk A/S Denmark
Ji Li, Executive Vice President, Global Head of Business Development, BeiGene
Bill Mendez, Vice President Alliance Management, BD Strategy & Operations, Pharma R&D, GSK
David Moller, Chief Scientific Officer, Sigilon Therapeutics
Ron Newbold, Senior Vice President and Head of US Business Development & Alliance Management, Otsuka America Pharmaceuticals
Oleg Nodelman, Founder and Managing Director, EcoR1
Carole Nuechterlein, Head, Roche Venture Fund
Michael O’Donnell, Partner, Morrison Foerster
Catherine Oyler, Global Head, Strategy & Operations, Johnson & Johnson External Innovation
Camille Samuels, Partner, Venrock
Andy Schwab, Founder and Managing Partner, 5AM Ventures
Armen Shanafelt, Ph.D., General Partner, Lilly Ventures
Jason Skolnik, Corporate and Securities Partner, Wilson Sonsini Goodrick & Rosati
Bob Smith, Senior Vice President, Global Gene Therapy Business, Rare Disease, Global Innovation Pharma, Pfizer Inc.
Avi Spier, Director, NIBR BD&L, Search and Evaluation, Novartis
Kumar Srinivasan, Vice President, Head of Scientific Partnering & Alliances, AstraZeneca
Darryl Steensma, Counsel, Latham & Watkins
Bruce Steel, Managing Director, BioMed Ventures
Ben Thorner, Senior Vice President and Head of Business Development & Licensing, Merck Ventures
DA Wallach, Recording Artist and Songwriter Turned Investor
Jeff Warmke, Senior Vice President, External Scientific Affairs, Daiichi Sankyo

DOWNLOAD CONFERENCE AGENDA

Company Presenters Announced
We had an overwhelming amount of interest to present during the company presentations for 2018! Congratulations to the following 25 companies that were selected to present:

3E Therapeutics
Abreos Biosciences
Amarantus BioScience
BioEclipse Therpaeutics, Inc.
Biological Dynamics
Coyne Scientific, LLC
CureMatch
Denovo Biopharma
Fulcrum Therapeutics
Hamamtsu University School of Medicine
Histogen
Leading BioSciences
MatriSys Bioscience
MDI Therapeutics, Inc.
Metacrine
Oncolytics Biotech, Inc.
Rapid Novor
Roswell Biotechnologies
Sanguine Biosciences
Sirius Japan
Sorrento Therapeutics
Synbal, Inc.
TREK Therapeutics
Viracta Therapeutics
XOMA Corporation

Price of Admission

Biocom Industry Member: Employee Head Count <10

Today’s Price: 895

Important Dates

Amount

Registration before 2018-01-08T01:00:00.000+0000

715

Registration before

Registration before

Registration cost

895

Refund before 2018-01-07

715

Refund before

Refund Before

*Refunds will no longer be accepted after 2018-01-07

Biocom Industry Member:Employee Head Count 10-100

Today’s Price: 1795

Important Dates

Amount

Registration before 2018-01-08T01:00:00.000+0000

1435

Registration before

Registration before

Registration cost

1795

Refund before 2018-01-07

1435

Refund before

Refund Before

*Refunds will no longer be accepted after 2018-01-07

Biocom Industry Member: Employee Head Count >100

Today’s Price: 2695

Important Dates

Amount

Registration before 2018-01-08T01:00:00.000+0000

2155

Registration before

Registration before

Registration cost

2695

Refund before 2018-01-07

2155

Refund before

Refund Before

*Refunds will no longer be accepted after 2018-01-07

Biocom Member: General/Service Provider

Today’s Price: 2970

Important Dates

Amount

Registration before 2018-01-08T01:00:00.000+0000

2375

Registration before

Registration before

Registration cost

2970

Refund before 2018-01-07

2375

Refund before

Refund Before

*Refunds will no longer be accepted after 2018-01-07

Non-Member: Industry: Employee Head Count <10

Today’s Price: 995

Important Dates

Amount

Registration before 2018-01-08T01:00:00.000+0000

795

Registration before

Registration before

Registration cost

995

Refund before 2018-01-07

795

Refund before

Refund Before

*Refunds will no longer be accepted after 2018-01-07

Non-Member: Industry: Employee Head Count 10-100

Today’s Price: 1995

Important Dates

Amount

Registration before 2018-01-08T01:00:00.000+0000

1595

Registration before

Registration before

Registration cost

1995

Refund before 2018-01-07

1595

Refund before

Refund Before

*Refunds will no longer be accepted after 2018-01-07

Non-Member: Industry: Employee Head Count >100

Today’s Price: 2995

Important Dates

Amount

Registration before 2018-01-08T01:00:00.000+0000

2395

Registration before

Registration before

Registration cost

2995

Refund before 2018-01-07

2395

Refund before

Refund Before

*Refunds will no longer be accepted after 2018-01-07

Non-Member: General/Service Provider

Today’s Price: 3300

Important Dates

Amount

Registration before 2018-01-08T01:00:00.000+0000

2640

Registration before

Registration before

Registration cost

3300

Refund before 2018-01-07

2640

Refund before

Refund Before

*Refunds will no longer be accepted after 2018-01-07

  • Lodging

    Hotel & Conference Location

    The Lodge at Torrey Pines
    11480 N. Torrey Pines Road
    La Jolla, CA 92037

    Conference Hotel Rate at The Lodge at Torrey Pines: $290/night plus tax

    All reservations must be made individually through the Hotel’s Reservation Department by calling (800)-656-0087; when booking, please identify yourselves as part of the Biocom 8th Annual Global Life Science Partnering Conference.

    Please note: If you need to cancel your room reservation at the Lodge at Torrey Pines, please ensure you do so by Monday, February 5th. After this date you will no longer be eligible for a refund on cancelled reservations, and your credit card will automatically be charged. Biocom will not be responsible for these fees.
     

  • Registration Policie

    All admission items with employee headcount breakdown pertains only to industry companies (biotech & pharma companies.) All other admissions fall under the category of general/service provider and must pay that rate, regardless of employee headcount. A service provider is a company that does not directly work with a substance that needs approval by the FDA and/or does business-to-business sales. They provide a service to the biotechnology and pharmaceutical industry and includes, but is not limited to, law firms, banks, laboratory equipment suppliers, consulting firms, or IT services.
    If a service provider company pays the industry fee, additional payment will be requested or registration may be canceled. 

    *Admission cancellations prior to February 16, 2018 will result in a full refund. No refunds will be granted after. If you are no longer able to attend you may send a substitute from the same company in your place.

    **No more than 2 attendees from a service provider company may attend the conference unless you are sponsoring the conference.

    To cancel or swap your registraion, please email Angela Wieszchowski at angelaw@biocom.org

     

Registration Closed